TARA - Long Setup Possible entry above 7.32, Stop signal 5.93., First target 8.37, 2nd target momentum. Strong insider buying
−6.13USD
−65.952MUSD
8.451M
About Protara Therapeutics, Inc.
Sector
CEO
Jesse Shefferman
Headquarters
New York
Website
Employees (FY)
25
Founded
2006
ISIN
US74365U1079
Protara Therapeutics, Inc. is a clinical-stage company engaged in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders. The company was founded by Jesse Shefferman and Jacqueline Zummo in March 2006 and is headquartered in New York, NY.
$TARA lets go whale hunting*This is not financial advice, so trade at your own risks*
*My team digs deep and finds stocks that are expected to perform well based off multiple confluences*
*Experienced traders understand the uphill battle in timing the market, so instead my team focuses mainly on risk management*
Early this
Protara Therapeutics Inc 🧙Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatmen
TARA Technical Analysis 🧙Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatmen
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
